Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
Clinical trial NCT06599619 · RECRUITING
Trial details
- NCT number
- NCT06599619
- Sponsor
- John Kirkwood
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-20
- Primary completion
- 2029-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.